Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe page now includes posted results with dates and the associated outcome measures, safety data, and QoL, plus links to the Study Protocol and Statistical Analysis Plan, reflecting updated documentation for the study record.SummaryDifference2%

- Check11 days agoChange DetectedA new citation was added for Amivantamab in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial (JAMA Otolaryngol Head Neck Surg, 2026 Apr 1). The prior online-ahead-of-print citation (Feb 26, 2026) was removed.SummaryDifference0.1%

- Check19 days agoChange DetectedThis updates the site’s displayed revision/version number from v3.5.0 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.SummaryDifference0.1%

- Check41 days agoChange DetectedPublication citation added: Hanna GJ et al. Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026 Feb 26:e255404. doi:10.1001/jamaoto.2025.5404. Online ahead of print. The previous entry for this publication was removed.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedResults Submitted replaces No Results Posted on the study page, indicating that the study results have been submitted.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.